Skip to main content
Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
24.23
-1.27 (-4.98%)
At close: Apr 28, 2026, 4:00 PM EDT
24.49
+0.26 (1.07%)
After-hours: Apr 28, 2026, 6:42 PM EDT

Damora Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Damora Therapeutics stock have an average target of 43, with a low estimate of 40 and a high estimate of 46. The average target predicts an increase of 77.47% from the current stock price of 24.23.

Analyst Consensus: Buy
Target Low Average Median High
Price $40 $43 $46 $46
Change +65.08% +77.47% +89.85% +89.85%

Analyst Ratings

The average analyst rating for Damora Therapeutics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Apr '26
Strong Buy 0
Buy 2
Hold 0
Sell 0
Strong Sell 0
Total 2

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Brian Abrahams
RBC Capital
 RBC Capital
Buy
Initiates
$40
 Buy Initiates $40 +65.08% Apr 24, 2026
Gavin Clark-Gartner
Evercore ISI Group
 Evercore ISI Group
Buy
Initiates
$46
 Buy Initiates $46 +89.85% Mar 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.42
from -153.95
EPS Next Year
-1.81
from -1.42
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-51.22-60.63-36.08-18.53-153.95-1.42-1.81
EPS Growth
-------
Forward PE
-------
No. Analysts -----55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027202820292030203120322033
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -

EPS Forecast

EPS 202620272028
High -1.05 -1.47
Avg -1.42 -1.81
Low -1.91 -1.99

EPS Growth

EPS Growth 202620272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.